Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (1.512)

1

Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital

enthalten in: European journal of hospital pharmacy : science and practice | 2024

von Pinilla Rello, A. | Magallón Martínez, A. | Vicente Iturbe, C. | +3

2

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID-19 : A systematic review and meta-analysis

enthalten in: Immunity, inflammation and disease | 2024

von Amani, B. | Amani, B.

3

Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England

enthalten in: BMC infectious diseases | 2024

von Patel, V. | Levick, B. | Boult, S. | +5

4

Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir) : a retrospective cohort study

enthalten in: BMC pharmacology & toxicology | 2024

von Yalan, Q. | Lingfang, H. | Xisong, L. | +3

5

Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity

enthalten in: Journal of pharmacy practice | 2024

von Troyer, B. | Kovacic Scherrer, N. | Garavaglia, J.

6

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

7

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma : TRAVERSE Continuation Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Maspero, J. | Peters, A. | Chapman, K. | +12

8

Real-world effectiveness of dupilumab in patients with asthma : Findings from the US ADVANTAGE study

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Blaiss, M. | Bleecker, E. | Jacob-Nara, J. | +9

9

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London : a retrospective cohort study

enthalten in: BMJ open respiratory research | 2024

von Drysdale, M. | Galimov, E. | Yarwood, M. | +11

10

Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls

enthalten in: The Journal of rheumatology | 2024

von Eviatar, T. | Furer, V. | Polachek, A. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[152]